Dublin, Calif. – Eksigent Technologies, LLC, creator of advanced nanofluidic technologies for life science research and medical device applications, announced today that David Weber has joined the company as CEO, President and Director. Weber joins the company from San Diego-based Stratagene Corporation, where he was Vice President of Global Marketing and Business Development and member of the Corporate Executive Committee. He also served as President of the Americas at Amersham Biosciences from 2001 to 2004. Weber brings to Eksigent more than 30 years experience in the life science and biotechnology industries, with sales and marketing positions at companies ranging in size from start-up to over $300 million in annual sales. Carl Berg, Eksigent Chairman of the Board and investor, stated, “We are excited to be able to attract a person of David’s experience, leadership ability, and industry knowledge to lead Eksigent at this very critical stage of our development and growth. Eksigent has an incredible life science technology platform and solid, experienced management is the key ingredient needed to propel the company forward as an industry leader. David is the right person at the right time to lead Eksigent.” “I am thrilled to join the Eksigent team and look forward to leading the company into the next phase of rapid growth. Eksigent couples a strong management team with outstanding technology in a way that can revolutionize life science research, drug delivery, and more,” comments Weber. Mr. Weber is a graduate in biochemistry from Rutgers University where he was a Henry Rutgers Scholar. He earned acceptance to and is a member of Phi Beta Kappa.